SRPT logo

Sarepta Therapeutics (SRPT)

Profile

Full Name

Sarepta Therapeutics, Inc.

Ticker Symbol

SRPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 4, 1997

Indexes

Not included

Website

http://www.sarepta.com

Employees

1372

Key Details

Price

$38.61(+3.71%)

Market cap

$3.79B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.90B(+52.97% YoY)

Annual EPS

$2.34(+140.34% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $38.61
    SRPT price is $38.61

    30-Day Relative Volume

    0.54
    SRPT 30-day relative volume is 0.54

    Price Performance

    Price Most recent change

    +3.71%
    SRPT price was up +3.71% on May 29, 2025

    Price YTD change

    -68.25%
    SRPT price is down -68.25% since January 1st

    Price 1-year change

    -66.79%
    SRPT price is down -66.79% year-on-year

    Price 3-year change

    -48.28%
    SRPT price is down -48.28% over the past 3 years

    Price Range

    Price All-time high

    $181.83
    SRPT price is currently -78.77% below its historical high of $181.83

    Price 3-year low

    $34.10
    SRPT price is currently +13.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.79B
    SRPT market capitalization is $3.79 billion

    Market cap 3-year change

    -41.91%
    SRPT market capitalization is down -41.91% over the past 3 years

    Market cap All-time high

    $15.60B
    SRPT market capitalization is currently -75.67% below its historical high of $15.60 billion

    Market cap sector rank

    87.57%
    SRPT market capitalization is higher than 87.57% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.97%
    SRPT shares outstanding is up +3.97% year-on-year

    Shares Outstanding 3-Year Change

    +12.32%
    SRPT shares outstanding is up +12.32% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.06
    SRPT beta is 1.06

    200-day SMA

    $103.95
    SRPT price is currently -62.86% below its 200-day simple moving average

    50-day SMA

    $53.71
    SRPT price is currently -28.11% below its 50-day simple moving average

    RSI

    34.84
    SRPT 14-day relative strength index is 34.84

    Volume

    0.54
    SRPT 30-day relative volume is 0.54

    ATR

    $2.48
    SRPT average true range is $2.48

    10-day Historical Volatility

    50.49%
    SRPT 10-day historical volatility is 50.49%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.90B
    SRPT annual revenue is $1.90 billion

    Revenue Analysts estimate

    $2.56B
    SRPT annual revenue is currently -25.61% lower than the consensus analysts' forecast

    Revenue 1-year change

    +52.97%
    SRPT annual revenue is up +52.97% year-on-year

    Revenue Sector rank

    84.45%
    SRPT annual revenue is higher than 84.45% of companies in Healthcare sector

    EPS

    EPS

    $2.34
    SRPT annual earnings per share is $2.34

    EPS Analysts estimate

    $0.10
    SRPT annual earnings per share is currently +2154.34% higher than the consensus analysts' forecast

    EPS 1-year change

    +140.34%
    SRPT annual earnings per share is up +140.34% year-on-year

    EPS Sector rank

    92.83%
    SRPT annual earnings per share is higher than 92.83% of companies in Healthcare sector

    Profit

    Gross profit

    $1.58B
    SRPT annual gross profit is $1.58 billion

    Gross margin

    83.22%
    SRPT annual gross profit margin is 83.22%

    Operating profit

    $218.08M
    SRPT annual operating income is $218.08 million

    Operating margin

    11.47%
    SRPT annual operating profit margin is 11.47%

    Net income

    $235.24M
    SRPT annual net profit is $235.24 million

    Net margin

    12.37%
    SRPT annual net profit margin is 12.37%

    Expenses

    Total expenses

    $1.68B
    SRPT annual total expenses is $1.68 billion

    Operating expenses

    $1.36B
    SRPT annual total operating expenses is $1.36 billion

    Cost of goods sold

    $319.10M
    SRPT annual cost of goods sold is $319.10 million

    Selling, general & administrative expenses

    $557.87M
    SRPT annual SGA is $557.87 million

    Depreciation and amortization

    $37.72M
    SRPT annual depreciation & amortization is $37.72 million

    Interest expense

    $18.39M
    SRPT annual interest expense is $18.39 million

    Income tax

    $25.54M
    SRPT annual income tax is $25.54 million

    EBIT & EBITDA

    EBIT

    $279.17M
    SRPT annual earnings before interest & taxes is $279.17 million

    EBITDA

    $316.89M
    SRPT annual EBITDA is $316.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.96B
    SRPT annual total assets is $3.96 billion

    Non current assets

    $889.71M
    SRPT annual long term assets is $889.71 million

    Current assets

    $3.07B
    SRPT annual total current assets is $3.07 billion

    Cash and cash equivalents

    $1.10B
    SRPT annual cash & cash equivalents is $1.10 billion

    Accounts receivable

    $601.99M
    SRPT annual accounts receivable is $601.99 million

    Inventory

    $749.96M
    SRPT annual inventory is $749.96 million

    Liabilities

    Total liabilities

    $2.44B
    SRPT annual total liabilities is $2.44 billion

    Long term liabilities

    $1.70B
    SRPT annual total long term liabilities is $1.70 billion

    Current liabilities

    $731.68M
    SRPT annual total current liabilities is $731.68 million

    Accounts payable

    $214.44M
    SRPT annual accounts payable is $214.44 million

    Debt

    Total debt

    $1.34B
    SRPT annual total debt is $1.34 billion

    Total debt 1-year change

    -3.85%
    SRPT annual total debt is down -3.85% year-on-year

    Long term debt

    $1.33B
    SRPT annual long term debt is $1.33 billion

    Short term debt

    $13.47M
    SRPT annual short term debt is $13.47 million

    Equity & Capital

    Shareholders equity

    $1.53B
    SRPT annual stockholders equity is $1.53 billion

    Book value

    $1.53B
    SRPT annual book value is $1.53 billion

    Retained earnings

    -$4.21B
    SRPT annual retained earnings is -$4.21 billion

    Working capital

    $2.34B
    SRPT annual working capital is $2.34 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$205.79M
    SRPT annual cash flow from operations is -$205.79 million

    Cash from operations 1-year change

    +58.92%
    SRPT annual cash flow from operations is up +58.92% year-on-year

    Cash from investing

    $755.56M
    SRPT annual cash flow from investing activities is $755.56 million

    Cash from investing 1-year change

    +555.7%
    SRPT annual cash flow from investing activities is up +555.7% year-on-year

    Cash from financing

    $124.81M
    SRPT annual cash flow from financing activities is $124.81 million

    Cash from financing 1-year change

    -0.16%
    SRPT annual cash flow from financing activities is down -0.16% year-on-year

    CAPEX

    CAPEX

    $146.96M
    SRPT annual capital expenditures is $146.96 million

    CAPEX 1-year change

    +68.25%
    SRPT annual capital expenditures is up +68.25% year-on-year

    Free Cash Flow

    Free cash flow

    -$352.74M
    SRPT annual free cash flow is -$352.74 million

    Free cash flow 1-year change

    +40.04%
    SRPT annual free cash flow is up +40.04% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    83.22%
    SRPT annual gross profit margin is 83.22%

    Operating margin

    11.47%
    SRPT annual operating profit margin is 11.47%

    Net margin

    12.37%
    SRPT annual net profit margin is 12.37%

    ROA & ROE

    ROA

    6.51%
    SRPT annual return on assets is 6.51%

    ROE

    19.71%
    SRPT annual return on equity is 19.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SRPT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SRPT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.32
    SRPT price to book ratio is 3.32

    PB ratio Sector rank

    71.94%
    SRPT price to book ratio is higher than 71.94% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.70
    SRPT price to sales ratio is 1.70

    PS ratio Sector rank

    37.38%
    SRPT price to sales ratio is higher than 37.38% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.90B
    SRPT enterprise value is $4.90 billion

    Enterprise value Sector rank

    87.78%
    SRPT enterprise value is higher than 87.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -45.98
    SRPT EV/EBITDA is -45.98

    EV/EBITDA Sector rank

    3.49%
    SRPT EV/EBITDA is higher than 3.49% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.20
    SRPT annual current ratio is 4.20

    Quick ratio

    3.18
    SRPT annual quick ratio is 3.18

    Leverage

    Debt to equity

    0.74
    SRPT annual debt to equity ratio is 0.74

    Interest coverage ratio

    15.18
    SRPT annual interest coverage ratio is 15.18

    Risk & Stability

    Piotroski F-Score

    1
    SRPT piotroski f-score is 1

    Altman Z-Score

    0.87
    SRPT altman z-score is 0.87

    Analyst ratings

    Recent major analysts updates

    May 22, 25 HC Wainwright & Co.
    Neutral
    May 20, 25 JP Morgan
    Overweight
    May 8, 25 Wells Fargo
    Overweight
    May 7, 25 RBC Capital
    Sector Perform
    May 7, 25 Piper Sandler
    Overweight
    May 7, 25 Oppenheimer
    Outperform
    May 7, 25 Needham
    Buy
    May 7, 25 Morgan Stanley
    Overweight
    May 7, 25 HC Wainwright & Co.
    Neutral
    May 7, 25 Guggenheim
    Buy

    Institutional Ownership

    Screeners with SRPT included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Sarepta Therapeutics?
    • Does Sarepta Therapeutics pay dividends?
    • What sector is Sarepta Therapeutics in?
    • What industry is Sarepta Therapeutics in?
    • What country is Sarepta Therapeutics based in?
    • When did Sarepta Therapeutics go public?
    • Is Sarepta Therapeutics in the S&P 500?
    • Is Sarepta Therapeutics in the NASDAQ 100?
    • Is Sarepta Therapeutics in the Dow Jones?
    • When was Sarepta Therapeutics's last earnings report?
    • When does Sarepta Therapeutics report earnings?
    • Should I buy Sarepta Therapeutics stock now?

    What is the ticker symbol for Sarepta Therapeutics?

    The ticker symbol for Sarepta Therapeutics is NASDAQ:SRPT

    Does Sarepta Therapeutics pay dividends?

    No, Sarepta Therapeutics does not pay dividends

    What sector is Sarepta Therapeutics in?

    Sarepta Therapeutics is in the Healthcare sector

    What industry is Sarepta Therapeutics in?

    Sarepta Therapeutics is in the Biotechnology industry

    What country is Sarepta Therapeutics based in?

    Sarepta Therapeutics is headquartered in United States

    When did Sarepta Therapeutics go public?

    Sarepta Therapeutics's initial public offering (IPO) was on June 4, 1997

    Is Sarepta Therapeutics in the S&P 500?

    No, Sarepta Therapeutics is not included in the S&P 500 index

    Is Sarepta Therapeutics in the NASDAQ 100?

    No, Sarepta Therapeutics is not included in the NASDAQ 100 index

    Is Sarepta Therapeutics in the Dow Jones?

    No, Sarepta Therapeutics is not included in the Dow Jones index

    When was Sarepta Therapeutics's last earnings report?

    Sarepta Therapeutics's most recent earnings report was on May 6, 2025

    When does Sarepta Therapeutics report earnings?

    The next expected earnings date for Sarepta Therapeutics is Aug 7, 2025

    Should I buy Sarepta Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page